Parameter
| Biomarker | EGFR | Full name | Epidermal Growth Factor Receptor | Molecular Type | Nucleic acid（DNA） |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Targeted therapy guidance |
| Disease | Non-Small Cell Lung Cancer | Disease Subtypes | / | ||
| Organ | Lung | Test Sample / Technology Platform | Tissue / Blood (Genetic Testing) | ||
| Pathobiological Mechanisms | Driver gene mutations, exon 19 deletion, exon 21 L858R point mutation, and other types enhance TKIs sensitivity | ||||
| Clinical Availability Status | Clinically available (targeted therapy screening) | ||||
| Notes and Dynamics | The incidence of lung adenocarcinoma in Asia is about 50% and is a core screening marker for targeted therapy | ||||